Showing results (1061-1070 of 4,634) with videos related to

Sort By:
Pageof 464
Anti-Cancer Drugs|March 3, 2025
BTK inhibitors enhance NKG2D ligand expression by regulating IL-10/STAT3 pathway in activated non-GCB diffuse large B-cell lymphoma cellsZhu-Xia Jia, Bi-Tao Xiao, Jin Li, et al.
Anti-Cancer Drugs|February 5, 2025
Long-term survival of an ALK fusion lung adenocarcinoma patient with high mutation burden and microsatellite instability high: a case reportYanrong Guo, Jinfang Zhai, Yanli Yang, et al.
Anti-Cancer Drugs|November 26, 2024
Induction of neuronal differentiation in glioma cells by histone deacetylase inhibitors based on Connectivity Map discoveryZhao-Qi Tang, Hong-Bin Xu, Chang Cao, et al.
Anti-Cancer Drugs|December 3, 2024
aYAP1-2 contributes to bFGF-induced proliferation In gastric cancerHui Chen, Di-Kai Xue, Yi-Xuan Wang, et al.
Anti-Cancer Drugs|March 10, 2025
Efficacy of disitamab vedotin (RC48) for previously treated human epidermal growth factor receptor 2-positive breast cancer with symptomatic brain metastases: a case report and review of the literatureCan Yang, Cui Zhang, Yisidan Huang, et al.
Anti-Cancer Drugs|October 18, 2024
Prophylactic role of pentoxifylline against paclitaxel-induced neuropathy among patients with breast cancer: a randomized-controlled trialMariam A Kidwani, Hasnaa Osama, Ahmed Hassan, et al.
Anti-Cancer Drugs|August 8, 2024
MET alterations as resistance mechanisms of dabrafenib-trametinib in BRAF p.V600E mutated non-small cell lung cancer patientMonica Pluchino, Irene Testi, Roberta Minari, et al.
Anti-Cancer Drugs|August 7, 2024
Targeting MCM2 activates cancer-associated fibroblasts-like phenotype and affects chemo-resistance of liposarcoma cells against doxorubicinChujie Bai, Shu Li, Zhichao Tan, et al.
Anti-Cancer Drugs|August 7, 2024
Integrated single-cell and bulk RNA sequencing analyses identify an immunotherapy nonresponse-related fibroblast signature in gastric cancerQian Peng, Peiling Zhang, Guolong Liu, et al.
Anti-Cancer Drugs|July 17, 2024
Regulation of cervical cancer via G15-mediated inhibition of G protein-coupled estrogen receptorZiyan Zhu, Xinyi Nie, Lexiu Deng, et al.
Pageof 464